Skip to main content

Table 1 The number of patients taking concomitant medications during this trial

From: A randomized double blind placebo controlled clinical trial of N-Acetylcysteine added to risperidone for treating autistic disorders

Medication (Mean dose)

N-Acetylcysteine+risperidone group (Number)

Placebo+risperidone group (Number)

Clonidine (0.75 mg/day)

5

3

Folic acid (1 mg/day)

2

0

Imipramine (10 mg/day)

1

0

Biperiden (2 mg/day)

1

1

Nortriptyline (12.5 mg/day)

1

0

Topiramate (12.5 mg/day)

0

2